MetaCap

Circle8 Group Inc. (CIRC)

NASDAQ: CIRCIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

0.1361-0.019 (-12.25%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CIRC stock chart

Technical analysis

Key statistics

All statistics
Market cap
$15.99M
EPS (TTM)
-$2.14
52-week range
0.136 – 4.56
Day range
0.1361 – 0.1658
Volume / Avg
416.97K / 1.13M
Beta
—

52-week range

$0.136$4.56

CIRC stock today

Shares of Circle8 Group (CIRC) finished lower on Nov 20 at $0.1361, a drop of 12.25% or $0.019 per share, versus the S&P 500's 3.70% decline. Trading was light, with 416.97K shares changing hands, about 37% of the average daily volume. Shares are 97.0% below their 52-week high of $4.56, set on Mar 16, 2026 and 0.1% above the 52-week low of $0.136, near the bottom of the past year's range.

CIRC is down 89.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 94.4%. Circle8 Group has posted a net loss over the last twelve months (EPS of -$2.14), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Circle8 Group

Company profile

Circle8 Group, Inc. provides talent management services. The company offers services, such as finding and engaging talent for various employment contracts, including secondment, interim positions, and temp-to-perm roles.

Industry
Biotechnology: Laboratory Analytical Instruments
CEO
Mr. Guus Franke
Headquarters
Englewood Cliffs, NJ
Employees
300
IPO year
2024

Financial highlights

Full financials

In fiscal 2025, Circle8 Group generated $435.9 million in revenue, down 1.5% from fiscal 2024, its first annual decline since 2022. Circle8 Group reported a net loss of $59.4 million, compared with a loss of $135.5 million a year earlier. Gross margin was 10.6% (down from 10.7%) and operating margin -11.5%.

Circle8 Group annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$435.88M$442.61M$401.37M$78.66K$210.00K
Growth-1.52%+10.27%+510171.81%-62.54%-36.27%
Net income$-59.43M$-135.48M$-15.25M$-4.09M$-3.70M
EPS (diluted)$-1.08$-3.68$-0.60$-12.38$-0.51

Earnings

Earnings history
Last reported (Sep/2026)
Nov 20, 2026
EPS actual vs est.
$-0.20 vs —

CIRC news

All CIRC news

Circle8 Group peers

Industrials sector
CIRC peer companies
CompanyPrice% ChgMarket capCompare
BNGOBionano Genomics Inc.0.8222-7.11%$11.50Mvs CIRC
ASTCAstrotech Corporation (DE)3.50-0.85%$7.45Mvs CIRC
EYPTEyePoint Inc.0.2342-11.36%$26.65Mvs CIRC
PRPOPrecipio Inc.17.35-6.17%$31.11Mvs CIRC
RPIDRapid Micro Biosystems Inc. Class A0.735-0.04%$37.37Mvs CIRC
HBIOHarvard Bioscience Inc.8.66-0.23%$39.60Mvs CIRC
SEERSeer Inc. Class A1.36-1.81%$75.91Mvs CIRC
QTRXQuanterix Corporation1.96-3.45%$93.06Mvs CIRC

Indexes, lists and sector

Circle8 Group stock FAQ

What is Circle8 Group's stock price today?

CIRC last traded at $0.1361 as of Nov 20, 4:00 PM EST, down 12.25% on the day. Prices are delayed at least 15 minutes.

Does Circle8 Group pay a dividend?

No. Circle8 Group does not currently pay a regular cash dividend.

Who is Circle8 Group's CEO?

Mr. Guus Franke is the chief executive officer of Circle8 Group Inc., which has about 300 employees.

Has CIRC ever split its stock?

Yes. The most recent CIRC stock split was a 1-for-40 split on Aug 31, 2023.

What is the CIRC 52-week high?

The 52-week high for CIRC is $4.56 and the 52-week low is $0.136. The stock is currently 97.0% below its high.

Compare CIRC